Eight Advisory supported Swissline by Dermalab S.A. on the acquisition of LABO Spa
Eight Advisory provided buy-side financial due diligence services to Swissline by Dermalab S.A. as part of the transaction
Swissline is a leading Swiss luxury skincare brand founded in 1989 specialising in high-performance anti-ageing solutions. The company combines biotechnological innovation with powerful botanical ingredients to offer premium skincare products such as the Cell Shock collection.
LABO Spa, founded in 2005 by Carole Nicolas and Carine Langenskiöld, is Zurich’s first day spa and a pioneer in the city’s wellness scene. The firm offers comprehensive wellness services, as well as facials performed by qualified beauticians, creating a tranquil environment for relaxation and rejuvenation.
The acquisition aims to combine advanced skincare solutions with holistic wellness practises. After 20 years of collaboration, this strategic move allows Swissline to strengthen its position in the luxury skincare market and create a comprehensive approach to the well-being of its customers. Swissline will relocate its headquarters to the heart of Zurich, where it will be located above the LABO Spa, fostering closer collaboration and improved service delivery.
Eight Advisory team members supporting this transaction:
- Financial buy-side due diligence: Patric Roth (Partner), Maximilian Schmoll (Manager), Linus Weber (Senior)
